- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: fibroblast growth factor receptor (FGFR)
Total 57796 results
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerJapan, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid NeoplasmUnited States
-
Providence Health & ServicesMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Hoffmann-La RocheCompleted
-
Aristotle University Of ThessalonikiCompleted
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Spectrum Pharmaceuticals, IncSuspended
-
Stanford UniversityNational Institutes of Health (NIH)Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Canada, Thailand, Vietnam, France, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, Russian Federation, China, Taiwan, United Kingdom, Czechia, Chile, Australia, Argentina, Slovakia, South Africa
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Belgium, Canada
-
University of UtahActive, not recruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)United States
-
Guangdong Association of Clinical TrialsActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Eli Lilly and CompanyAstraZenecaCompletedNon-small Cell Lung CancerSpain, United States, Korea, Republic of, Taiwan, France
-
Memorial Sloan Kettering Cancer CenterXcovery Holding Company, LLCActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
Erasca, Inc.Active, not recruitingGlioblastoma MultiformeUnited States
-
Boehringer IngelheimCompleted
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
Accutar Biotechnology IncTerminated
-
Zeno Pharmaceuticals, Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States, Bosnia and Herzegovina
-
Incyte CorporationAstraZenecaActive, not recruitingLung CancerUnited States, Korea, Republic of, Spain, Taiwan
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingHR-positive, HER2-negative Breast NeoplasmsChina
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
University of Maryland, College ParkMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.; Children's National Research InstituteCompleted
-
M.D. Anderson Cancer CenterWithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Hormone Receptor Positive Breast Adenocarcinoma | Metastatic HER2 Negative Breast AdenocarcinomaUnited States
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer...Active, not recruitingRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A | Fibroblast Growth Factor Basic Form Measurement | FLT3 Internal Tandem DuplicationUnited States
-
Eisai Co., Ltd.Active, not recruiting
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
PfizerCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Breast Carcinoma | Cancer of BreastIndia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerJapan, Poland, United States, Australia, Belgium, Brazil, Canada, China, Colombia, Costa Rica, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, New Zealand, Portugal, Puerto Rico, Russian Federation, Spain, Taiwan, Ukr... and more
-
PfizerCompleted
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.CompletedMetastatic Breast CancerUnited States, Japan
-
Institut du Cancer de Montpellier - Val d'AurelleActive, not recruiting
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
Boehringer IngelheimCompleted
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China